FDA OKs Bausch + Lomb preservative-free eye drop

  • Bausch Health Companies (NYSE:BHC) and Eton Pharmaceuticals (NASDAQ:ETON) announce the FDA nod for Alaway Preservative Free ophthalmic solution antihistamine eye drops as the first over-the-counter (OTC) preservative-free formulation eye drop.
  • "We expect Alaway Preservative Free will be available for purchase in the Spring of 2021 at major retailers in time for the start of allergy season." says Joe Gordon, U.S. president, Bausch + Lomb.
  • An affiliate of Bausch Health acquired the U.S. rights to Alaway Preservative Free from Eton in 2019.
  • BHC +1.2% PM; ETON +4.6% PM
  • Press Release

Recommended For You

Comments (38)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.